V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190005847 | 190005658 | null | 92.9 | null | null | 2015-10-21 | null | null | N | MIFAMURTIDE | 101547571 |
| 190005863 | 190005662 | null | null | null | null | 2019-08-14 | null | null | null | MIFAMURTIDE | 101480889 |
| 190005904 | 190005667 | null | 53 | null | null | 2016-07-27 | null | 02 | N | MIFAMURTIDE | 101311078 |
| 190005939 | 190005672 | null | null | null | null | 2019-08-21 | null | null | null | MIFAMURTIDE | 101607237 |
| 190006183 | 190005699 | 1.73 | 39.3 | null | 2016-03-31 | 2016-08-05 | null | null | null | MIFAMURTIDE | 100092411 |
| 190006355 | 190005725 | null | 45.9 | Curative (C) | null | 2019-07-11 | null | 02 | N | MIFAMURTIDE | 101536020 |
| 190006415 | 190005735 | null | null | null | null | 2019-03-29 | null | 02 | null | MIFAMURTIDE | 100701975 |
| 190006514 | 190005758 | null | 49.5 | Adjuvant (A) | null | 2017-09-19 | null | N | N | MIFAMURTIDE | 100317469 |
| 190006630 | 190005775 | null | null | Neo-adjuvant (N) | null | 2016-10-02 | null | null | null | MIFAMURTIDE | 101493865 |
| 190006712 | 190005790 | null | null | null | null | 2019-06-13 | null | null | null | MIFAMURTIDE | 100026338 |
| 190006759 | 190005801 | 1.8 | 86.6 | Palliative (P) | 2021-11-28 | 2021-11-29 | Cisplatin | 02 | N | CISPLATIN | 101316247 |
| 190006764 | 190005802 | 1.64 | 85 | Curative (C) | null | 2017-06-05 | ETOPOSIDE + IFOSFAMIDE + MTX | null | null | DOCETAXEL | 101164994 |
| 190006768 | 190005803 | 1.68 | 59.2 | null | null | 2016-03-29 | NB HRNBL-1 COJEC Ind COURSE C | Y | N | CAPECITABINE + OXALIPLATIN | 101011222 |
| 190006779 | 190005804 | 1.68 | 68.7 | Palliative (P) | null | 2017-01-12 | GEMCITABINE + NAB PACLITAXEL | null | null | CISPLATIN + GEMCITABINE | 100504252 |
| 190006783 | 190005805 | 1.61 | 67.4 | null | 2017-03-08 | 2017-03-08 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | CISPLATIN + FLUOROURACIL | 101329351 |
| 190006799 | 190005807 | 1.89 | 71 | Curative (C) | 2019-01-09 | 2019-01-23 | CISPLATIN + ETOPOSIDE | 2 | Y | CAPECITABINE + OXALIPLATIN | 100664205 |
| 190006800 | 190005808 | 1.56 | 73.8 | Curative (C) | 2017-03-07 | 2017-09-13 | OST Euramos 1 Closed Trial - IE | N | N | AVELUMAB | 101094021 |
| 190006820 | 190005810 | 1.62 | 80.9 | Palliative (P) | 2016-12-07 | 2016-12-08 | Gemcitabine day 1&8 | 02 | null | CAPECITABINE + OXALIPLATIN | 101322674 |
| 190006823 | 190005811 | 0 | 61.7 | Curative (C) | 2018-07-30 | 2019-02-02 | GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101504882 |
| 190006829 | 190005812 | 1.74 | 53.3 | Curative (C) | 2016-10-13 | 2016-10-27 | GemCarbo Days 1+8 | 01 | N | PACLITAXEL | 100921122 |
| 190006844 | 190005813 | 1.7 | 84.4 | Curative (C) | 2018-06-23 | 2018-06-25 | EURAMOS TRIAL | 01 | N | PACLITAXEL | 100445431 |
| 190006853 | 190005814 | 1.62 | 82 | null | 2021-08-04 | 2021-08-12 | Cisplatin + Fluorouracil + Streptozocin | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101813862 |
| 190006855 | 190005815 | 0 | 15.4 | null | null | 2018-05-20 | NB HRNBL-1 COJEC Ind COURSE C | N | N | NIVOLUMAB | 101250750 |
| 190006866 | 190005816 | 1.75 | 120 | Neo-adjuvant (N) | null | 2017-10-16 | Trabectedin | 2 | null | DOCETAXEL | 101075297 |
| 190006869 | 190005817 | 1.76 | 54.6 | null | 2015-04-03 | 2016-08-06 | EW EuroEwing 99 : VActI | Y | N | CISPLATIN + ETOPOSIDE | 101142086 |
| 190006880 | 190005818 | 1.84 | 115 | Curative (C) | 2021-02-20 | 2021-02-23 | STS Non-Rhabdo EpSSG 2005 VDCy | 01 | N | CAPECITABINE + IRINOTECAN | 100352964 |
| 190006887 | 190005819 | 1.69 | 44.2 | Curative (C) | null | 2017-11-09 | Ribociclib | null | null | FLUOROURACIL + OXALIPLATIN | 100625828 |
| 190006891 | 190005820 | 1.57 | 72.3 | Neo-adjuvant (N) | 2017-05-04 | 2017-05-04 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101311680 |
| 190006895 | 190005821 | null | 86.8 | Curative (C) | null | 2019-11-20 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | null | RITUXIMAB | 100644335 |
| 190006897 | 190005822 | 1.6 | 92.1 | Palliative (P) | 2020-04-09 | 2020-10-05 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 100842510 |
| 190006902 | 190005823 | 1.53 | 44.9 | Curative (C) | 2020-03-18 | 2020-03-18 | EW EuroEwing 2012 Arm A VAI | 02 | N | TRIAL | 100656991 |
| 190006919 | 190005824 | 1.8 | 44 | null | 2019-11-08 | 2019-11-20 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101018181 |
| 190006923 | 190005825 | 1.65 | 70.8 | Curative (C) | null | 2017-04-19 | OST Euramos 1 Closed Trial - AP | null | null | FLUOROURACIL + MITOMYCIN | 101679873 |
| 190006927 | 190005826 | 1.57 | 96.7 | Palliative (P) | null | 2018-07-12 | EURO-EWING | 01 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100395443 |
| 190006929 | 190005827 | 1.68 | 96.65 | Palliative (P) | 2017-09-09 | 2018-04-17 | EW EuroEwing 2012 Arm A VAI | 01 | N | CAV | 101030233 |
| 190006959 | 190005828 | 1.98 | 23.3 | null | 2020-02-08 | 2020-02-08 | Trial Unspecified | 02 | N | EVEROLIMUS | 100858620 |
| 190006961 | 190005829 | 1.82 | 87.9 | null | 2019-07-23 | 2019-07-28 | GEMCITABINE | Y | N | CISPLATIN + RT | 101243207 |
| 190006963 | 190005830 | 1.8 | 41.4 | Neo-adjuvant (N) | null | 2016-10-08 | Cyclophosphamide + Topotecan | null | null | CISPLATIN + RT | 100403203 |
| 190006964 | 190005831 | 1.81 | 72.4 | Palliative (P) | 2022-01-14 | 2022-02-08 | CISPLATIN + RT | 02 | null | CAPECITABINE | 100348099 |
| 190006966 | 190005832 | 1.82 | 55.5 | null | 2017-06-28 | 2017-07-03 | CAPECITABINE + CARBOPLATIN | null | null | FLUOROURACIL + OXALIPLATIN | 100549979 |
| 190006971 | 190005833 | 0 | 0 | Curative (C) | 2016-12-06 | 2017-01-31 | Avelumab | 01 | N | CISPLATIN + ETOPOSIDE | 101199807 |
| 190006979 | 190005834 | 0 | 52.7 | null | 2017-05-13 | 2017-10-25 | Carboplatin + Etoposide iv&po | 02 | N | RIBOCICLIB | 101171123 |
| 190006993 | 190005835 | null | 105.2 | null | 2018-08-10 | 2018-09-01 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | CISPLATIN + GEMCITABINE | 100530857 |
| 190007002 | 190005836 | 1.62 | 62.7 | Adjuvant (A) | null | 2017-12-10 | NB HRNBL-1 COJEC Ind COURSE C | null | null | CISPLATIN + FLUOROURACIL | 100555135 |
| 190007039 | 190005837 | 1.69 | 57 | Palliative (P) | 2018-05-12 | 2018-05-12 | Gemcitabine day 1&8 | 02 | N | GEMCITABINE + TREOSULFAN | 101850175 |
| 190007040 | 190005838 | 1.57 | 64 | Neo-adjuvant (N) | 2016-07-03 | 2016-07-12 | OST R/R OLIE IE Ifosfamide, Etoposide | 02 | N | TRIAL UNSPECIFIED | 101242287 |
| 190007041 | 190005839 | 1.8 | 91.1 | Adjuvant (A) | 2021-12-22 | 2021-12-28 | MAP + MIFAMURTIDE | 01 | N | FLUOROURACIL + OXALIPLATIN | 100298617 |
| 190007048 | 190005840 | null | null | Palliative (P) | null | 2020-01-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100592254 |
| 190007054 | 190005841 | 1.8 | 92.3 | Palliative (P) | null | 2019-09-17 | Irinotecan + Modified De Gramont | 02 | null | PEMBROLIZUMAB | 100013421 |
| 190007067 | 190005842 | 1.79 | 49.1 | 03 | 2021-06-26 | 2021-06-27 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 101097695 |